Ahmad Ab Rahman
The treasury of wealth perished while they are alive, and the scholars remain as long as time remains.
Ali Ibn Abi Talib AS
Dr Ahmad Sufian Ab Rahman MBChB, FRACP, Fellowship Cancer Clinical Trials. Dr Ahmad Sufian is a consultant medical oncologist, internal medicine physician, and a clinician researcher who received his full medical training in New Zealand and Australia. He completed his post-doc medical oncology fellowship in cancer clinical trials at NHMRC Clinical Trials Centre, Sydney, and John Hopkins certificate programs in clinical trials and systematic reviews. He was awarded and admitted as a fellow of Royal Australasian College of Physician (RACP). His oncology interest has been in the spheres of cancer genomics and precision oncology, immunotherapy, clinical trials, drug development, data science in oncology, and cancer health inequities. He is an active member of various oncology organizations including ASCO, ESMO, AACR, and various cancer cooperative groups in Asia Pacific. He serves as an Asia Pacific medical oncologist with registration and involvement in Malaysia, Australia, and New Zealand. In Malaysia, he serves as a consultant medical oncologist at UCSI Hospital Negeri Sembilan, and Columbia Asia Hospital Bukit Rimau, Selangor. Dr Ahmad Sufian founded Cancer CRI Centre Malaysia in May 2021 and established this social business model to advance the cancer care, research and innovation ecosystem in Malaysia. Through this, he started to champion the discourse on cancer genomics, molecular profiling, and precision oncology in Malaysia. He started the Southeast Asia oncology tumour board program in 2022 and engage with various cancer stakeholders in the field of cancer genomics in Malaysia, Asia and at a global level.
New Zealand national retrospective cohort study of survival outcomes of patients with metastatic melanoma receiving immune-checkpoint inhibitors